Bridge City Capital, LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1713521 LAKE OSWEGO, OR

Position in TGTX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,010,861

New position

Shares Held

90,634

first reported quarter

Ownership

0.059%

of shares outstanding

% of Portfolio

0.83%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 55% Shared 0% None 45%

Healthcare · as of Mar 31, 2026

Bridge City Capital, LLC holds $13,944,831 across 5 Biotechnology names. TGTX ranks #3 (21.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	155,689	$3,854,859
2	KRYS	Krystal Biotech, Inc.	12,045	$3,111,464
3	TGTX	Tg Therapeutics, Inc. This page	90,634	$3,010,861
4	CORT	Corcept Therapeutics Inc	54,874	$2,211,970
5	VCEL	Vericel Corp	54,575	$1,755,677

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,010,861	90,634	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.